Detection of BCR/ABL gene in chronic Myeloid Leukaemia: comparison of Fluorescence in situ Hybridisation (FISH), conventional Cytogenetics and Polymerase Chain Reaction (PCR) techniques by Reena RMZ, et al.
Med & Health 2006; 1(1): 5-13 
 
Detection of BCR/ABL Gene in Chronic Myeloid Leukaemia: 
Comparison of Fluorescence in situ Hybridisation (FISH), 
Conventional Cytogenetics and Polymerase Chain Reaction 
(PCR) Techniques   
 
1Reena RMZ, 1Julia Munchar MJ, 1Salwati S, 2Zubaidah Z, 1Hamidah NH, 
1Sharifah NA, 1Cheong SK. 
 
1 Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan 
Yaacob Latif, Bandar Tun Razak, Cheras, Kuala Lumpur. 
2 Division of Haematology, Institute of Medical Research, Jalan Pahang, Kuala Lumpur 
 
 
ABSTRAK 
 
Translokasi salingan t(9; 22)(q34; q11) yang  menghasilkan kromosom Philadelphia (Ph1) 
dan juga gen lakuran BCR/ABL memainkan peranan utama dalam diagnosis dan 
patogenesis penyakit leukemia myeloid kronik (CML). Didalam kajian ini, kami mengkaji 
peranan teknik  pendaflor in situ hibridasasi (FISH) dalam mengesan gen lakuran 
BCR/ABL pada 18 sampel aspirasi sumsum tulang daripada pesakit CML dan pesakit 
yang disyaki menghidap CML. Kami juga membuat analisa perbandingan mengenai 
kesensitifan, spesifisiti dan kadar pengesanan gen lakuran BCR/ABL di antara teknik 
penghibridan pendaflor (FISH), kariotip sitogenetik dan tindak balas berantai polimerase 
(PCR). Sensitiviti, spesifisiti dan kadar pengesanan untuk FISH adalah 100% untuk 
kesemuanya. Untuk kariotip sitogenetik pula, sensitiviti, spesifisiti dan kadar pengesanan 
adalah 85%, 100% dan 100% masing- masing. Kariotip sitogenetik juga telah mengesan 
sejenis aberasi kromosom di samping Ph1. Kajian ini menunjukkan kaedah FISH adalah 
sangat sensitif dalam mengesan gen lakuran BCR/ABL. Kariotip sitogenetik tetap menjadi 
salah satu kaedah utama dalam penyiasatan pesakit CML kerana terdapat kebarangkalian 
mengesan aberasi kromosom disamping Ph1. Oleh itu, kariotip sitogenetik dan FISH 
adalah dua teknik (komplementari) yang saling melengkapi dalam pengesanan gen 
lakuran BCR/ABL pada pesakit CML. 
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ABSTRACT 
 
The reciprocal translocation t(9;22)(q34;q11) which gives rise to the Philadelphia (Ph1) 
chromosome and BCR/ABL fusion gene, plays a pivotal role in the diagnosis and 
pathogenesis of chronic myeloid leukemia (CML). In this study, we evaluated the role of 
fluorescence in situ hybridisation (FISH) in detecting the BCR/ABL rearrangement in CML 
patients. The sensitivity, specificity and detection rate of BCR/ABL gene using FISH, PCR 
and conventional cytogenetics (karyotyping) methods were also compared. 18 bone 
marrow samples of patients with clinically diagnosed CML and suspected of CML were 
collected. The sensitivity, specificity and positive predictive values of FISH were altogether  
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100% while the sensitivity, specificity and positive predictive values for conventional 
cytogenetics (karyotyping) were 85%, 100% and 100% respectively. Convetional 
cytogenetics (karyotyping) detected an additional chromosomal aberration in addition to 
the Ph1 chromosome. In conclusion, FISH is a highly sensitive method in detecting the 
BCR/ABL gene. Conventional cytogenetics (karyotyping) remains an important 
investigation in the work up of suspected CML patients since there is a possibility of 
detecting chromosomal aberrations in addition to the Ph1 translocation. Therefore, 
conventional cytogenetics (karyotyping) and FISH are complementary techniques and their 
results should be interpreted together with clinical information. 
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INTRODUCTION 
 
Chronic myeloid leukaemia (CML) is a 
malignant clonal myeloproliferative disorder 
affecting the pluripotent haematopoietic 
stem cell that can give rise to an increase 
of myeloid, erythroid cells and platelet in 
the peripheral blood, and myeloid 
hyperplasia of the bone marrow. The 
natural history of CML involves a triphasic 
phase from the chronic phase to an 
accelerated phase and then finally the blast 
phase. 
Chronic myeloid leukaemia is dis-
tinguished from other chronic myelo-
proliferative disorders by the presence of a 
distinctive chromosomal abnormality, 
termed the Philadelphia or Ph1 chromo-
some. This was the first consistent chromo-
somal abnormality identified in cancer 
(Nowell 1960). The Philadelphia (Ph1) 
chromosome results from a reciprocal 
translocation between the long arms of 
chromosomes 9 and 22 [t(9;22)(q34;q11] 
and is present in at least 95 % of patients 
with CML (Nowell 1960). The Ph1 chromo-
some is also present in 5% of children and 
20% of adults with acute lymphoblastic 
leukaemia (ALL) (Hagemeijer, 1987). In 
CML, there is a  translocation of part of the 
long arm of chromosome 22 to the long 
arm of chromosome 9 and reciprocal 
translocation of part of the long arms of 
chromosome 9 to chromosome 22 (Ph1 
chromosome). In the BCR gene, the 
breakpoint occurs within a region of 5.8 kb, 
known as the major breakpoint cluster 
region (M-BCR) (Heisterkamp 1985). The 
majority of breakpoints occur between 
exons b2 and b3 or b3 and b4 of the M-
BCR giving rise to b2a2 or b3a2 chimeric 
messenger RNA (mRNA) (Heisterkamp 
1985). Both transcripts encode a p210 
protein with prominent tyrosine kinase 
activity and transforming ability. This 
elevated tyrosine kinase activity plays an 
important role in the pathogenesis of the 
disease (Daley 1990). In the ABL gene, the 
breakpoint may occur anywhere within a 
region larger than 300kb upstream of the 
exon 1b, between exons 1b and 1a, or 
downstream from exon 1a.  
Due to this distinctive chromosomal and 
molecular abnormality, the detection of the 
t(9;22)(q34;q11) or the BCR/ABL re-
arrangement is necessary for the diagnosis 
of CML and for monitoring of treatment 
response. The techniques of detection 
include conventional karyotyping and mole-
cular analysis. In about 5% of cases 
diagnosed clinically as CML, no Ph1 
chromosome is observed (De Klein 1982). 
These cases have either more complex 
translocations involving other chromo-
somes besides chromosome 9 and 22 or 
presence of cryptic BCR/ABL rearrange-
ment (Kurzrock 1990). However, molecular 
analyses have shown that BCR/ABL is 
present in about half of these patients 
(Kurzrock 1990). Hence molecular analysis 
complement karyotyping by identifying 
abnormal clones undetected by karyo-
typing.  
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Conventional cytogenetics or karyo-
typing, is the standard method to study 
proliferating cells in CML. Generally, they 
are based on analysis of up to 25 
metaphases and can be used as a 
screening method to detect chromosome 
anomalies. The major advantage of 
chromosome analysis in CML is the 
possibility of detecting chromosome 
aberrations such as trisomy 8 and 
isochromosome 17, in addition to the Ph1 
chromosome (Nanjangud 1994). On the 
other hand, chromosome analyses are 
cumbersome, time consuming, labour 
intensive and dependent on high numbers 
of viable dividing cells. 
Fluorescence in situ hybridisation or 
FISH is rapidly becoming part of clinical 
practice in the workup of patients with 
haematological malignancies. FISH permits 
analysis of proliferating (metaphase cells) 
and non-proliferating (interphase nuclei) 
cells by detecting the location of specific 
nucleic acid sequences, using chromo-
some specific DNA probes. These DNA 
probes contain a label (fluorescence) that 
allows their detection after hybridisation to 
the target of interest (Cox 1998). FISH has 
been used to reliably identify the BCR/ABL 
gene at the time of diagnosis (Cox 1998). 
Increasing usage of FISH probes have also 
successfully detected a variety of mole-
cular-cytogenetics variants. Using FISH 
analysis, several studies have identified 
cases with additional phenomena to the 
translocation, such as large deletions of the 
derivative chromosome 9, which has been 
reported to have a worse prognosis 
(Sinclair 2000). 
The advantages of FISH are significant. 
It can be performed overnight and so it is 
particularly useful for situations which 
require diagnostic urgency. It is also easy 
to analyse large numbers of cells and the 
results are reproducible. It can be 
performed on various types of specimens, 
which include fixed cell pellets left over 
from cytogenetic studies on bone marrow 
or blood (Dewald 1998). They also work 
well with peripheral blood smears, touch 
preparations and paraffin embedded 
tissues (Paternoster, In press). 
Reverse transcriptase polymerase chain 
reaction (RT-PCR) is another method of 
molecular analysis in detecting the 
BCR/ABL translocation. It is a highly 
sensitive technique for the detection of 
BCR/ABL mRNA. Using PCR, one can 
detect leukaemia specific mRNA se-
quences extracted from as few as one cell. 
The technique consists of two parts. The 
first part involves the synthesis of cDNA 
(complementary DNA) from RNA by 
reverse transcription. The second part 
involves the amplification of a specific 
cDNA by PCR. In our study, we have 
considered PCR as the gold standard. 
Several studies have addressed the 
issue of which is the clinically most useful 
approach for the detection of BCR/ABL 
rearrangement in Ph1 positive patients. Cox 
et al in 1998 reported that the sensitivity of 
PCR and FISH related to Ph1 positive 
cases were 97% and 100% respectively 
with 5% false positive results by PCR. In 
another study on 40 samples of Ph1 
positive related disorders, Tbakhi et al 
(1998) found that FISH and PCR were 
positive in 100% of CML samples. In these 
two studies, both of them had utilised 
conventional cytogenetics (karyotyping) as 
their gold standard.  Both of these studies 
had concluded that either FISH or PCR 
procedure offers a specific, cost effective 
and faster alternative to karyotyping. Both 
of these studies had analysed all the Ph1 
related disorders which include CML, acute 
lymphoblastic leukaemia and acute 
myeloid leukaemia. 
The present study aims to evaluate the 
role of FISH in detecting the BCR/ABL 
rearrangement in clinically diagnosed CML 
patients. A comparative analysis between 
FISH (molecular cytogenetics) and conven-
tional karyotyping were carried out utilising 
PCR as our gold standard. The signal 
patterns obtained using the BCR/ABL ES 
(Extra Signal) FISH probes were also 
studied. 
 
7 
Reena RMZ et. al. 
 
Med & Health 2006; 1(1): 5-13
METHODOLOGY AND MATERIALS Total RNA isolation and cDNA synthesis 
  
Mononuclear cells from fresh bone marrow 
aspirates were isolated by Histopaque 
density gradient centrifugation. The 
mononuclear layer was aspirated into a 5 
mL tube and stored at –80oC. The  RNA 
extraction was performed using the acid 
guanidinium thiocyanate - phenol - chloro-
form extraction (AGPC) method.  
This is a cross sectional study on all cases  
diagnosed with CML at various stages of 
therapy and those suspected of CML from 
Hospital Universiti Kebangsaan Malaysia 
(HUKM) recruited between January 2003 
and December 2004. Cytogenetics, PCR 
and double colour ES FISH analyses were 
performed on the samples for the presence 
of BCR/ABL gene rearrangement.  Routine 
diagnostic procedures for these patients 
consisted of morphology and differential 
white blood cell counts on bone marrow 
and peripheral blood. Diagnosis of CML 
was made by clinical findings, bone 
marrow aspirate and neutrophil alkaline 
phospahatase score. Patients with other 
forms of myeloproliferative disease 
including Acute Lymphocytic Leukemia 
(ALL) and Acute Myeloid Leukemia (AML) 
were not included. 
Complementary DNA (cDNA) synthesis 
was done using 5X RT buffer, MgCl2, PCR 
nucleotide mix, Rnasin, random hexamers 
and Moloney murine leukemia virus 
reverse transcriptase (M-MLVRT, Promega 
Corp). RNA sample was initially transferred 
into a PCR tube and heated at 70oC for 10 
minutes using a thermocycler. After a quick 
chill in ice, cDNA mix was then added to 
the RNA sample. PCR was performed on 
the mixed cDNA sample consisting of 1 
cycle at 37oC for 90 minutes and 65oC for 
10 minutes. The sample was then stored at 
–20oC. 
 
Conventional Cytogenetics (Karyotyping) 
  Samples of bone marrow were cultured 
and harvested following standard protocol 
(Barch 1997). Details of the karyotype were 
reported according to ISCN 1995. 
Reverse Transcriptase - Polymerase Chain 
Reaction (RT-PCR) 
 
Master mix for PCR (distilled water, 10x 
PCR buffer, primers, 10mM of PCR 
nucleotide mix and 25 mM of MgCl2, 
Promega Corp) was added to the PCR 
tube along with cDNA sample. After a 
hotstart of 1 min at 94oC, 0.5 uL of Taq 
DNA polymerase was added to each 
sample. PCR was performed on an 
automated thermocycler which consisted of 
35 cycles at 94oC for 1 minute, 65oC for 50 
seconds, 72oC for 1 minute, and final 
extension at 72oC for 10 minutes. Reaction 
products were electrophoresed on a 1.5% 
agarose gel with ethidium bromide staining 
for 45 minutes at 80V. The products were 
then visualised under ultraviolet light. 
 
Fluorescence in situ Hybridisation (FISH) 
 
ES (extrasignal) FISH analysis was 
performed on the same bone marrow 
samples harvested for cytogenetics 
examination and following manufacturer’s 
protocol (Vysis Inc. Downers Grove, 
Illinois, USA). Hybridisation signals were 
evaluated using BX60 fluorescence 
microscope equipped with appropriate 
filters for simultaneous visualization of 
fluorescein isothiocynate (FITC) and tetra-
methylrhodamine isothiocynate (TRITC) 
fluorescence. 
  Reverse Transcriptase - Polymerase Chain 
Reaction (RT-PCR) RESULTS AND DISCUSSION   
In this study, we considered PCR as the 
gold standard in the diagnosis of CML. We 
adopted strict precautions and conditions 
to avoid contamination.  
Eighteen cases were studied by 
conventional karyotyping, FISH and RT-
PCR. The results are presented in Table 1. 
BCR/ABL mRNA was detected in 13 of 
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TABLE 1. Patient’s characteristics and results of cytogenetics, FISH and RT-PCR. 
 
Patient 
No 
Age Sex Hb 
(g/dL) 
Leucocyte 
x10/mm3 
Karyotyping result FISH 
result 
RT- PCR 
result 
1 33 M 5.7 120 46XY, t(9;22)(q34;q11.1) BCR/ABL BCR/ABL 
2 61 M 11 195 46XY, t(9;22)(q34;q11.1) BCR/ABL BCR/ABL* 
3 38 M 14.7 75.4 46XY,-22, t(9;22)(q34;q11.1)der (3), 
+mar 
BCR/ABL BCR/ABL 
4 50 F 11.1 21.6 No metaphase BCR/ABL BCR/ABL 
5 25 M 13.4 96.6 46XY, t(9;22)(q34;q11.1) BCR/ABL BCR/ABL 
6 31 F 12.3 6.5 46XX, t(9;22)(q34;q11.1) BCR/ABL BCR/ABL 
7 29 M 11.4 154.6 46XY 
t(9;22)(q34;q11.1) 
BCR/ABL 
 
BCR/ABL 
8 26 M 11.8 23.7 Very few cells Not 
performed 
BCR/ABL 
9 39 F 8.4 17.6 47XX,+8,i(17q),t(9;22)(q34;q11.1)X2 BCR/ABL BCR/ABL 
10 36 M 14.6 22.1 46XY, t(9;22)(q34;q11.1) BCR/ABL BCR/ABL 
11 40 M 8.8 158 46XY, t(9;22)(q34;q11.1) BCR/ABL BCR/ABL 
12 32 F 8.3 182 46XX, t(9;22)(q34;q11.1) BCR/ABL BCR/ABL 
13 29 F 10.5 84.2 46XX, t(9;22)(q34;q11.1) BCR/ABL BCR/ABL 
14 77 M 9.4 9.0 46XY,No abnormal karyotype No fusion 
gene 
No fusion 
gene 
mRNA 
15 45 F 9.8 7.3 46XX,No abnormal karyotype No fusion 
gene 
No fusion 
gene 
mRNA 
16 53 F 7.8 12.2 46XX,No abnormal karyotype No fusion 
gene 
No fusion 
gene 
mRNA 
17 34 M 7.5 3.1 46XY,No abnormal karyotype No fusion 
gene 
No fusion 
gene 
mRNA 
18 43 M 7.6 3.5 46XY,No abnormal karyotype No fusion 
gene 
No fusion 
gene 
mRNA 
 
*  RT-PCR performed on initial sample showed insufficient mRNA. However, a repeat 
RT-PCR performed on follow up sample was BCR/ABL positive 
9 
Reena RMZ et. al. 
 
Med & Health 2006; 1(1): 5-13
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1 
FIGURE 3 
FIGURE 2 
FIGURE 4 
 
 
FIGURE 1.  Presence of Ph1 chromosome t(9;22)(q34;q11.1) by conventionl karyotyping. 
 
FIGURE 2.  Interphase FISH showing presence of BCR/ABL gene fusion. One orange, one 
green and one fused orange and green signal is seen in all the nucleus 
possessing t(9;22). 
 
FIGURE 3.  Presence of extra copy of chromosome 8 (trisomy 8)( ↑ ) and isochromosome 
17q ( ↑ ) in addition to Philadelphia chromosome ( ↑ ) in patient 9. 
 
FIGURE 4.  FISH analysis confirmed presence of two BCR/ABL fusion gene in patient 9. 
Cytogenetic analysis showed presence of two Ph1 chromosomes, an extra 
copy of chromosome 8 (trisomy 8) and an isochromosome 17q (Figure 3) 
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TABLE 2.  Correlation between Conventional Cytogenetics and RT-PCR. 
 
RT-PCR  
Methods mRNA+ mRNA-
Cytogenetics Ph1+ 11 0 
Cytogenetics Ph1- 2 5 
Total 13 5 
 
 
 
 
TABLE 3.  Correlation between FISH and RT-PCR. 
 
 
 RT-PCR  
 Methods mRNA+ mRNA-
FISH BCR/ABL + 12 0 
FISH BCR/ABL - 0 5 
Total 12 5 
 
 
 
 
 
 
 
 
 
 
 
TABLE 4.  Correlation between Conventional Cytogenetics and FISH. 
 
FISH  
Methods BCR/ABL + BCR/ABL -
Cytogenetics (Ph1 +) 11 0 
Cytogenetics (Ph1 -) 0 5 
Total 12 5 
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these samples (72%). The remaining five 
samples did not show presence of 
BCR/ABL mRNA. Eleven patients (61%) 
were Ph1 positive (Table 1 and Figure 1) 
and all of them showed presence of 
BCR/ABL mRNA by PCR. Two out of the 
remaining seven samples did not have any 
metaphase and showed very few cells 
respectively. However, these two samples 
were proven mRNA positive by PCR. The 
other five samples showed normal 
karyotype with no abnormalities seen. For 
conventional karyotyping, the sensitivity, 
specificity, positive predictive value (PPV) 
and negative predictive value (NPV) were 
85%, 100%, 100% and 71% respectively 
(Table 2). The accuracy for conventional 
karyotyping method was 88%. The lower 
sensitivity was obviously due to a smaller 
number of samples utilised in our study. A 
previous larger study has quoted sensitivity 
of at least 95% (De Klein 1982). In patient 
9, there was presence of an extra copy of 
chromosome 8 (trisomy 8) and iso-
chromosome 17q (Figure 3). Seventeen 
samples were evaluable for FISH analysis. 
FISH was not performed on one sample 
due to insufficient material. Twelve 
samples (71%) showed presence of 
BCR/ABL fusion gene by FISH analysis 
(Table 1 and Figure 2) and all of these 
twelve samples showed presence of 
BCR/ABL mRNA by PCR. The remaining 
five samples did not show presence of the 
fusion gene by FISH. The sensitivity, 
specificity, PPV and NPV for FISH were all 
100% (Table 3). The accuracy for FISH 
analysis was 100%. Previous studies have 
quoted sensitivities of FISH between 80% 
and 100% (Cox 1998, Tkachuk 1990). 
FISH had also confirmed presence of two 
BCR/ABL fusion genes in one patient. The 
cytogenetic analysis of this patients’ 
sample also showed presence of two Ph1 
chromosomes (Figure 3 and Figure 4). 
From our study, we detected the BCR/ABL 
fusion gene in 12 of 17 samples analysed 
by FISH method (Table 4). The possibility 
of a false positive result by FISH was ruled 
out because the PCR finding on this 
sample was BCR/ABL mRNA positive.  
Based on results of conventional 
cytogenetics (karyotyping) in our study, we 
acknowledge that conventional cyto-
genetics (karyotyping) has its limitations. 
We could not obtain any metaphase 
spread in one of our samples and in 
another sample, only very few cells were 
present. The proportions of metaphases 
identified in cytogenetics depend on 
several factors, such as the number of 
metaphases analysed and the method 
used for obtaining metaphases. These 
metaphases only represent a small 
proportion of the total cells of a sample. 
However, conventional cytogenetics 
(karyotyping) has its strength because it is 
able to detect additional nonrandom 
chromosomal changes. 
In conclusion, the ES fluorescence in 
situ hybridisation (FISH) technique is a 
highly sensitive and accurate method for 
detection of the BCR/ABL fusion gene. 
Despite several limitations, conventional 
karyotyping, however, will remain an 
important investigation in the work up of 
suspected CML patients since there is a 
possibility in detecting chromosomal 
aberrations in addition to the Ph1 
translocation. Therefore, conventional cyto-
genetics (karyotyping) and FISH are 
complementary techniques and their 
results should be interpreted together with 
clinical information and other molecular 
studies. 
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